This ccRCC cell line was established from a novel electroporation-derived ccRCC syngeneic model that carries CRISPR-mediated deletion of Vhl, Tp53, and Rb1 (25). This evidence concerns the gene TP53 and nonpapillary renal cell carcinoma.